Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. (Q46733585)

24 December 2017

title

Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. (English)

1 reference

24 December 2017

1 reference

David F Penson

0 references

Steven B Zeliadt

1 reference

24 December 2017

Arnold L Potosky

series ordinal

1 reference

24 December 2017

Ruth Etzioni

series ordinal

1 reference

24 December 2017

Scott D Ramsey

series ordinal

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

24 December 2017

published in

Urology

1 reference

24 December 2017

volume

1 reference

24 December 2017

issue

1 reference

24 December 2017

page(s)

1171-1176

1 reference

24 December 2017

The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

Trends in the utilization of androgen-deprivation therapy for patients with prostate carcinoma suggest an effect on mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

The prostate cancer conundrum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

National practice patterns and time trends in androgen ablation for localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

Studying radiation therapy using SEER-Medicare-linked data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

Treatments for prostate cancer in older men: 1984-1997.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

Follow-up prostate cancer treatments after radical prostatectomy: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

Development of a comorbidity index using physician claims data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

Racial/ethnic disparities in the treatment of localized/regional prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

Trends and black/white differences in treatment for nonmetastatic prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

Racial and ethnic disparities in the receipt of cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

7 January 2021

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

Osteoporosis due to androgen deprivation therapy in men with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

Androgen deprivation therapy for asymptomatic advanced prostate cancer in the prostate specific antigen era: a national survey of urologist beliefs and practices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.07.037

10.1016/J.UROLOGY.2004.07.037

7 January 2021

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017